Clinical and Laboratory Issues in Community-acquired MRSA.


The prevalence of Methicillin-resistant Staphylococcus aureus (MRSA) has steadily increased over the past 40 years. Today, intravenous clindamycin or vancomycin is recommended for anti-staphylococcal coverage. Failure to identify resistant strains could result in the overuse of vancomycin and subsequent resistance to that antibiotic. Concerns over the… (More)
DOI: 10.5863/1551-6776-9.2.82


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics